Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine.
Social Support is Key to Retention in Care during Covid-19 Pandemic among Older People with HIV and Substance Use Disorders in Ukraine.
复制标题
DOI：
10.1080/10826084.2020.1791183
复制
发表时间：
2020
影响因子：
2
通讯作者：
Yariy V
中科院分区：
文献类型：
--
作者：
Rozanova J;Shenoi S;Zaviryukha I;Zeziulin O;Kiriazova T;Rich K;Mamedova E;Yariy V
患有人类免疫缺陷病毒-艾滋病毒（OPWH）定义为≥50岁的老年人在乌克兰新诊断感染中所占比例越来越大（2018年为16%），但乌克兰OPWH中药物使用障碍的患病率仍然未知。乌克兰于二零二零年三月下旬采取全面封锁措施应对新型冠状病毒疫情。我们于2020年5月在基辅对患有物质使用障碍（SUD）的OPWH进行的电话调查数据表明，尽管患有SUD的OPWH在COVID-19封锁期间维持了艾滋病毒和SUD治疗，但社会支持对于避免患有SUD的OPWH的治疗中断至关重要。在重新开放期间，减少支持可能会导致OPWH感到更加孤立。在没有社会支持的情况下，后COVID-19药物治疗SUD的方法就像没有汽油的车辆。未来对OPWH患者的研究议程必须包括确定远程医疗支持的类型，以最有效地保留OPWH，包括注射毒品的人（PWID），由非专业卫生工作者提供支持，以及此类干预措施的成本效益。所吸取的经验教训可能也适用于其他国家。
Older people with human immunodeficiency virus - HIV (OPWH) defined as ≥50 years old account for a growing proportion of newly diagnosed infections in Ukraine (16% in 2018), but prevalence of substance use disorder among OPWH in Ukraine remains unknown. Ukraine responded to the Covid-19 pandemic with a comprehensive lockdown in late March 2020. Data from a phone survey we conducted among OPWH with substance use disorders (SUD) in Kyiv in May 2020 demonstrated that while OPWH with SUD maintained HIV and SUD therapy throughout Covid-19 lockdown, social support is critical to avoiding treatment interruption for OPWH with SUD. During reopening, reduction of support may lead to OPWH feeling even more isolated. Post-Covid-19 pharmacological approaches to SUD treatment without social support are like vehicles without gas. The research agenda for OPWH patients with SUD going forward must include determining the type of telehealth support that will be optimally effective to retain OPWH including people who inject drugs (PWID), provision of support by lay health workers, and cost effectiveness of such interventions. The lessons learned may be relevant to other countries as well.
登录
查看更多内容
影响因子：
3.2
作者：
Rozanova, Julia;Marcus, Ruthanne;Altice, Frederick L.
通讯作者：
Altice, Frederick L.
影响因子：
1.8
作者：
Lancaster, Kathryn E.;Miller, William C.;Latkin, Carl A.
通讯作者：
Latkin, Carl A.
影响因子：
16.1
作者：
Booth, Robert E.;Davis, Jonathan M.;Dvoryak, Sergey;Brewster, John T.;Lisovska, Oksana;Strathdee, Steffanie A.;Latkin, Carl A.
通讯作者：
Latkin, Carl A.
DOI：
10.1056/nejmoa1506816
发表时间：
2015-08-27
期刊：
The New England journal of medicine
影响因子：
--
作者：
INSIGHT START Study Group;Lundgren JD;Babiker AG;Gordin F;Emery S;Grund B;Sharma S;Avihingsanon A;Cooper DA;Fätkenheuer G;Llibre JM;Molina JM;Munderi P;Schechter M;Wood R;Klingman KL;Collins S;Lane HC;Phillips AN;Neaton JD
通讯作者：
Neaton JD
DOI：
10.1097/qad.0000000000001417
发表时间：
2017-04-24
期刊：
AIDS (London, England)
影响因子：
--
作者：
Lifson AR;Grund B;Gardner EM;Kaplan R;Denning E;Engen N;Carey CL;Chen F;Dao S;Florence E;Sanz J;Emery S;INSIGHT START Study Group
通讯作者：
INSIGHT START Study Group